Tilos Therapeutics
USEntry
2016
Hold
3yr
Exit
2019
Who owns Tilos Therapeutics?
Tilos Therapeutics was owned by Boehringer Ingelheim Venture Fund through Boehringer Ingelheim Venture Fund (2010 vintage) from 2016 to 2019, exited via Trade Sale.
Buyer identity available on Pro.
Hand-verified · updated 2026-07-07
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2019
More from Boehringer Ingelheim Venture Fund
Other portfolio companies in the same fund.
Germany
Switzerland
France
UKMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Tilos Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Tilos Therapeutics?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Tilos Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue